Keyhole oesophageal cancer surgery as good as more invasive operations

September 7, 2017
Keyhole oesophageal cancer surgery as good as more invasive operations
Credit: Cancer Research UK

Keyhole surgery for oesophageal cancer is as good as more invasive surgery in terms of survival, according to unpublished clinical trial results.

There may also be benefits in reducing complications for after .

Professor Rebecca Fitzgerald, a Cancer Research U.K.-funded expert in oesophageal cancer at the University of Cambridge, said the study should give reassurance that is just as good an operation, which should be better for patient recovery.

The unpublished results from the phase 3 European MIRO trial were presented to the ESMO 2017 Congress in Madrid.

The study included 207 patients who were followed for an average of more than 4 years. Half had keyhole surgery and half had more invasive 'open' surgery, which is standard treatment.

After three years, 67 percent of keyhole surgery patients were alive, compared to 55 percent of patients.

Just over a third of keyhole surgery patients (36 percent) had major complications after their operation, compared to just under two thirds of patients (64 percent) who had problems after open surgery.

Professor Tim Underwood, a Cancer Research U.K.-funded expert in gastrointestinal surgery at the University of Southampton, said: "This well-conducted study shows that keyhole surgery for oesophageal is at least as good as open surgery in terms of long term survival. There may also be a benefit by reducing complications after surgery."

In comparing surgical approaches it's important to measure the success in removing as much of the tumour as possible, while reducing the amount of normal tissue affected.

These factors affect whether or not the patient will require further surgery and the time taken to recover.

These results suggest that patient safety is not compromised by the keyhole approach, and that patients have reduced surgical trauma.

"Removing all or part of the oesophagus is a very invasive procedure with significant quality of life issues," said Fitzgerald. "Anything that can be done to improve patient experience and reduce hospital and recovery time after surgery is ideal."

Patients included in the MIRO trial had cancers affecting the middle or lower third of the oesophagus.

"Before we know if these results are true in the U.K. population we need to see the results of the U.K. ROMIO study, which is currently recruiting," added Underwood.

Lead investigator Dr Guillaume Piessen, from University Hospital C. Huriez Place de Verdun in Lille, said that the results show that keyhole surgery is a clinically sound procedure for .

Explore further: MIRO trial: 3-year outcomes favour laparoscopic surgery for oesophageal cancer

More information: Mariette, C. et al. (2017) Esophageal Cancer: Long-term outcomes of a multicenter, open-label, randomized phase III controlled trial, the MIRO trial. www.esmo.org/content/download/ … 17-Abstract-Book.pdf

Related Stories

MIRO trial: 3-year outcomes favour laparoscopic surgery for oesophageal cancer

September 5, 2017
Patients requiring surgery for oesophageal cancer fare better after undergoing a hybrid minimally invasive oesophagectomy (HMIO) compared to an open oesophagectomy (OO), according to long-term results of the MIRO trial to ...

Laparoscopic surgery achieves similar survival rates in rectal cancer

April 2, 2015
(HealthDay)—Patients with localized rectal cancer may achieve similar survival rates by having minimally invasive laparoscopic surgery, instead of more invasive open surgery, according to new research published in the April ...

Weekday of surgery affects oesophageal cancer surgery prognosis

November 18, 2015
Patients who undergo surgery for oesophageal cancer early in the week – on a Monday or Tuesday – have a higher chance of long-term survival than those who have surgery at the end of the working week. This is according ...

Women with aortic aneurysms fare much worse than men, new study finds

April 25, 2017
The findings, published today in The Lancet, show women fare worse than men at every stage of treatment, leading to the study's authors to call for urgent improvement in how the condition is managed in women.

Recommended for you

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

Wider sampling of tumor tissues may guide drug choice, improve outcomes

November 15, 2017
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.